Suppr超能文献

水泡希瓦氏菌HM13产生的膜泡作为低温下分泌生产异源蛋白的潜在平台

Membrane Vesicles Produced by Shewanella vesiculosa HM13 as a Prospective Platform for Secretory Production of Heterologous Proteins at Low Temperatures.

作者信息

Kawamoto Jun, Kurihara Tatsuo

机构信息

Institute for Chemical Research, Kyoto University, Uji, Kyoto, Japan.

出版信息

Methods Mol Biol. 2022;2414:191-205. doi: 10.1007/978-1-0716-1900-1_12.

Abstract

Extracellular membrane vesicles (EMVs) produced by Gram-negative bacteria are useful as a vaccine platform. During growth in broth at 18 °C, Shewanella vesiculosa HM13 produces a large number of EMVs that contain a 49-kDa major cargo protein, named P49. Enhanced green fluorescent protein fused to the C-terminus of P49 is delivered to EMVs, suggesting that P49 is useful as a carrier to target foreign proteins to EMVs for production of artificial EMVs with desired functions. This method is potentially useful for the preparation of designed vaccines and is described in detail in this chapter.

摘要

革兰氏阴性菌产生的细胞外膜泡(EMV)可作为一种疫苗平台。在18℃肉汤中生长时,水泡希瓦氏菌HM13会产生大量含有一种名为P49的49 kDa主要载脂蛋白的EMV。与P49 C端融合的增强型绿色荧光蛋白被递送至EMV,这表明P49可作为一种载体,将外源蛋白靶向至EMV,以生产具有所需功能的人工EMV。该方法在设计疫苗的制备中具有潜在用途,本章将对此进行详细描述。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验